The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women's health, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier screening, preimplantation genetic screening, and preimplantation genetic diagnosis used in IVF process; IVF medical devices, systems, and equipment; and PARAGARD, a non-hormonal, copper intrauterine device for birth control. Further, The Cooper Companies, Inc. offers its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNYSE:COO
CUSIP21664840
Phone925-460-3600
Debt
Debt-to-Equity Ratio0.77
Current Ratio2.76
Quick Ratio1.67
Price-To-Earnings
Trailing P/E Ratio26.40
Forward P/E Ratio21.72
P/E Growth2.03
Sales & Book Value
Annual Sales$2.14 billion
Price / Sales5.89
Cash Flow$13.6285 per share
Price / Cash18.84
Book Value$64.88 per share
Price / Book3.96
Profitability
EPS (Most Recent Fiscal Year)$9.70
Net Income$372.90 million
Net Margins5.58%
Return on Equity17.14%
Return on Assets9.68%
Miscellaneous
Employees11,800
Outstanding Shares49,100,000
Market Cap$12.65 billion
Cooper Companies (NYSE:COO) Frequently Asked Questions
What is Cooper Companies' stock symbol?
Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."
How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?
Cooper Companies announced a semiannual dividend on Friday, July 13th. Shareholders of record on Monday, July 23rd will be paid a dividend of $0.03 per share on Tuesday, August 7th. This represents a yield of 0.02%. The ex-dividend date is Friday, July 20th. View Cooper Companies' Dividend History.
How will Cooper Companies' stock buyback program work?
Cooper Companies declared that its board has initiated a stock buyback program on Friday, April 7th 2017, which allows the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 5.2% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board believes its shares are undervalued.
How were Cooper Companies' earnings last quarter?
Cooper Companies Inc (NYSE:COO) posted its quarterly earnings results on Thursday, June, 7th. The medical device company reported $2.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.84 by $0.02. The medical device company earned $631.30 million during the quarter, compared to the consensus estimate of $627.49 million. Cooper Companies had a return on equity of 17.14% and a net margin of 5.58%. The business's revenue for the quarter was up 20.8% compared to the same quarter last year. During the same quarter last year, the company earned $2.50 EPS. View Cooper Companies' Earnings History.
When is Cooper Companies' next earnings date?
What guidance has Cooper Companies issued on next quarter's earnings?
Cooper Companies updated its FY18 earnings guidance on Thursday, June, 7th. The company provided earnings per share (EPS) guidance of $11.70-11.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.79. The company issued revenue guidance of $2.52-2.55 billion, compared to the consensus revenue estimate of $2.53 billion.
What price target have analysts set for COO?
12 Wall Street analysts have issued 12 month price objectives for Cooper Companies' shares. Their forecasts range from $231.00 to $285.00. On average, they expect Cooper Companies' stock price to reach $265.40 in the next year. This suggests a possible upside of 3.4% from the stock's current price. View Analyst Price Targets for Cooper Companies.
What is the consensus analysts' recommendation for Cooper Companies?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies.
Who are some of Cooper Companies' key competitors?
Some companies that are related to Cooper Companies include Express Scripts (ESRX), Illumina (ILMN), Boston Scientific (BSX), HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX), Humana (HUM), Zoetis (ZTS), FRESENIUS SE &/S (FSNUY), BEXIMCO PHARMAC/S GDR REGS (BXP), Regeneron Pharmaceuticals (REGN), Baxter International (BAX), ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), ESSILOR Intl S/S (ESLOY) and Actelion (ALIOF).
Who are Cooper Companies' key executives?
Cooper Companies' management team includes the folowing people:
- Mr. Albert G. White III, Pres, CEO & Director (Age 48)
- Mr. Daniel G. McBride Esq., Chief Operating Officer, Exec. VP and Pres of CooperVision Inc (Age 54)
- Mr. Agostino Ricupati, Chief Accounting Officer and Sr. VP of Fin. & Tax
- Ms. Carol R. Kaufmann, Advisor (Age 69)
- Mr. Brian Andrews, Sr. VP, CFO & Treasurer
Has Cooper Companies been receiving favorable news coverage?
News stories about COO stock have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cooper Companies earned a coverage optimism score of 0.10 on Accern's scale. They also assigned news headlines about the medical device company an impact score of 46.56 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Cooper Companies.
Who are Cooper Companies' major shareholders?
Cooper Companies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.40%), Massachusetts Financial Services Co. MA (6.22%), Janus Henderson Group PLC (5.33%), Frontier Capital Management Co. LLC (1.68%), Bessemer Group Inc. (1.54%) and Bank of New York Mellon Corp (0.82%). Company insiders that own Cooper Companies stock include A Thomas Bender, Albert G White III, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss, Stanley Md Zinberg and William A Kozy. View Institutional Ownership Trends for Cooper Companies.
Which major investors are selling Cooper Companies stock?
COO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, American Century Companies Inc., Wells Fargo & Company MN, Sawgrass Asset Management LLC, Voya Investment Management LLC, Virginia Retirement Systems ET AL, Strs Ohio and Russell Investments Group Ltd.. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Michael Kalkstein, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.
Which major investors are buying Cooper Companies stock?
COO stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Massachusetts Financial Services Co. MA, Findlay Park Partners LLP, Putnam Investments LLC, Frontier Capital Management Co. LLC, Bessemer Group Inc., Advisors Asset Management Inc. and Waddell & Reed Financial Inc.. View Insider Buying and Selling for Cooper Companies.
How do I buy shares of Cooper Companies?
Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cooper Companies' stock price today?
One share of COO stock can currently be purchased for approximately $256.76.
How big of a company is Cooper Companies?
Cooper Companies has a market capitalization of $12.65 billion and generates $2.14 billion in revenue each year. The medical device company earns $372.90 million in net income (profit) each year or $9.70 on an earnings per share basis. Cooper Companies employs 11,800 workers across the globe.
How can I contact Cooper Companies?
Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]
MarketBeat Community Rating for Cooper Companies (NYSE COO)
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
